The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research

This long-term observational study in China collects detailed data on how acromegaly — a condition caused by a pituitary tumor that produces excess growth hormone, leading to abnormal bone and tissue growth — is treated in real-world clinical practice and how patients respond over time. Researchers aim to understand treatment patterns, clinical outcomes, and the economic burden of acromegaly treatment across Chinese hospitals. Adults aged 18 to 75 with a confirmed diagnosis of acromegaly (based on elevated growth hormone levels and imaging evidence of a pituitary tumor) may be eligible. Participation involves sharing medical information from existing records and follow-up visits as part of routine clinical care — no experimental treatments are assigned. This summary was generated with AI assistance to help patients understand the study in plain language.